Cancers | Free Full-Text | A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis
IJMS | Free Full-Text | The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker
Frontiers | A Novel Paradigm Between Leukocytosis, G-CSF Secretion, Neutrophil-to-Lymphocyte Ratio, Myeloid-Derived Suppressor Cells, and Prognosis in Non-small Cell Lung Cancer
Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells | Cancer Gene Therapy
Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung - Hsiao - 2022 - Cancer Medicine - Wiley Online Library
Pharmaceuticals | Free Full-Text | Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
JCM | Free Full-Text | Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
Effects of primary granulocyte‑colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review - ScienceDirect
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide - ScienceDirect
Frontiers | GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors | British Journal of Cancer
Frontiers | Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Frontiers | Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation - ScienceDirect
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer | Scientific Reports
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF) | SpringerLink
Overall survival curves of G-CSF group (solid line) and | Download Scientific Diagram
Frontiers | G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer | British Journal of Cancer
Cancers | Free Full-Text | Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
Lung cancer - The Lancet
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy - Transplantation and Cellular Therapy, Official Publication of the ...
Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation | Chinese Medical Journal
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma | Journal for ImmunoTherapy of Cancer
Cancers | Free Full-Text | G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth
